The impact of renin-angiotensin-aldosterone system inhibitors on Type 1 and Type 2 diabetic patients with and without early diabetic nephropathy

The impact of renin-angiotensin-aldosterone system inhibitors on Type 1 and Type 2 diabetic patients with and without early diabetic nephropathy

Taispeáin leaganacha eile (1)

Renin-angiotensin-aldosterone system inhibitors prevent the progression of kidney disease in patients with diabetic nephropathy, and we studied how that benefit varies by the type of diabetes and baseline urinary albumin. We pooled data from 49 randomized controlled trials in a meta-analysis using t...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Taylor, K, Stevens, R, Blacklock, C, Roberts, N, Pugh, C, Farmer, A, Hirst, J
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	2012

Míreanna comhchosúla

The impact of renin-angiotensin-aldosterone system inhibitors on Type 1 and Type 2 diabetic patients with and without early diabetic nephropathy.
de réir: Hirst, J, et al.
Foilsithe / Cruthaithe: (2012)

Evidence for a dose effect of renin-angiotensin system inhibition on progression of microalbuminuria in Type 2 diabetes: a meta-analysis.
de réir: Blacklock, C, et al.
Foilsithe / Cruthaithe: (2011)

Advances in the Renin-Angiotensin-Aldosterone System: Relevance to Diabetic Nephropathy
de réir: Audrey Koitka, et al.
Foilsithe / Cruthaithe: (2008-01-01)

Renin Angiotensin Aldosterone System Gene Polymorphisms among Type 2 Diabetic Patients with Retinopathy and Nephropathy
de réir: Vaishali S. Pawar, et al.
Foilsithe / Cruthaithe: (2024-12-01)

View on the problem of diabetic nephropathy in children and adolescents with type 1 diabetes: the role of renin-angiotensin-aldosterone system (literature review) (part 2)
de réir: K. V. Skobeleva, et al.
Foilsithe / Cruthaithe: (2021-06-01)

Dual Blockade of the Renin-angiotensin-aldosterone System in Type 2 Diabetic Kidney Disease
de réir: Yan-Huan Feng, et al.
Foilsithe / Cruthaithe: (2016-01-01)

View on the problem of diabetic nephropathy in children and adolescents with type 1 diabetes mellitus: the role of renin-angiotensin-aldosterone system (literature review) (part 1)
de réir: K. V. Skobeleva, et al.
Foilsithe / Cruthaithe: (2021-06-01)

Renin‐Angiotensin‐Aldosterone System, Glucose Metabolism and Incident Type 2 Diabetes Mellitus: MESA
de réir: Joshua J. Joseph, et al.
Foilsithe / Cruthaithe: (2018-09-01)

Network pharmacology combined with Mendelian randomization analysis to identify the key targets of renin-angiotensin-aldosterone system inhibitors in the treatment of diabetic nephropathy
de réir: Dongqi Zhou, et al.
Foilsithe / Cruthaithe: (2024-01-01)

New Approaches to Blockade of the Renin–Angiotensin–Aldosterone System: Overview of Regulation of the Renin–Angiotensin–Aldosterone System
de réir: Akira Nishiyama, et al.
Foilsithe / Cruthaithe: (2010-01-01)

The efficacy and safety of dual blockage of the renin-angiotensin-aldosterone system in patients with type 2 diabetes, hypertension and obesity without renal dysfunction
Foilsithe / Cruthaithe: (2012-09-01)

Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19
de réir: Andre Feldman, et al.
Foilsithe / Cruthaithe: (2020-11-01)

Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19
de réir: Andre Feldman, et al.
Foilsithe / Cruthaithe: (2020-11-01)

Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19
de réir: Andre Feldman, et al.
Foilsithe / Cruthaithe: (2020-11-01)

Renin-angiotensin-aldosterone system inhibitors and the COVID-19 epidemic
de réir: José Silva-Cardoso, et al.
Foilsithe / Cruthaithe: (2022-10-01)

How to potentialize the effect of renin-angiotensin-aldosterone system inhibitors?
de réir: D.D. Ivanov
Foilsithe / Cruthaithe: (2021-09-01)

Use of maximal dosage renin-angiotensin-aldosterone system inhibitors in a real life population of complicated type 2 diabetes – contraindications and opportunities
de réir: C. M. Gant, et al.
Foilsithe / Cruthaithe: (2023-08-01)

Analysis of renin-angiotensin aldosterone system gene polymorphisms in Malaysian essential hypertensive and type 2 diabetic subjects
de réir: Ramachandran, Vasudevan, et al.
Foilsithe / Cruthaithe: (2009)

Analysis of renin-angiotensin aldosterone system gene polymorphisms in malaysian essential hypertensive and type 2 diabetic subjects
de réir: Stanslas Johnson, et al.
Foilsithe / Cruthaithe: (2009-02-01)

Association of renin-angiotensin system genes polymorphism with progression of diabetic nephropathy in patients with type 1 diabetes mellitus
de réir: Ilić Vesna, et al.
Foilsithe / Cruthaithe: (2014-01-01)

Effects and Safety of Linagliptin as an Add-on Therapy in Advanced-Stage Diabetic Nephropathy Patients Taking Renin–Angiotensin–Aldosterone System Blockers
de réir: Yuichiro Ueda, et al.
Foilsithe / Cruthaithe: (2016-01-01)

Effects and Safety of Linagliptin as an Add-on Therapy in Advanced-Stage Diabetic Nephropathy Patients Taking Renin–Angiotensin–Aldosterone System Blockers
de réir: Yuichiro Ueda, et al.
Foilsithe / Cruthaithe: (2016-09-01)

Novel Class of Central Renin Angiotensin Aldosterone System Inhibitor: Firibastat
Foilsithe / Cruthaithe: (2022-05-01)

Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19: A Review
de réir: Filipe Ferrari, et al.
Foilsithe / Cruthaithe: (2021-04-01)

Renin‐Angiotensin Aldosterone System Inhibitors in Primary Prevention and COVID‐19
de réir: Jordan Loader, et al.
Foilsithe / Cruthaithe: (2021-08-01)

Genetic polymorphism of renin-angiotensin-aldosterone system in type 2 diabetes and in combination with arterial hypertension among Dagestan inhabitants
de réir: Marat Z. Saidov, et al.
Foilsithe / Cruthaithe: (2019-12-01)

The renin angiotensin aldosterone system and COVID-19
de réir: Hadeel A. Alsufyani, et al.
Foilsithe / Cruthaithe: (2020-08-01)

Beyond the circulating renin angiotensin aldosterone system
de réir: Walmor eDe Mello
Foilsithe / Cruthaithe: (2014-07-01)

Influence of renin‐angiotensin‐aldosterone system inhibitors on plasma levels of angiotensin‐converting enzyme 2
de réir: Tobias Zimmermann, et al.
Foilsithe / Cruthaithe: (2021-04-01)

Dynamic Changes in the Renin-Angiotensin-Aldosterone System and the Beneficial Effects of Renin-Angiotensin-Aldosterone Inhibitors on Spatial Learning and Memory in a Rat Model of Chronic Cerebral Ischemia
de réir: Xinwu Huang, et al.
Foilsithe / Cruthaithe: (2017-06-01)

New Approaches to Blockade of the Renin–Angiotensin–Aldosterone System: Characteristics and Usefulness of the Direct Renin Inhibitor Aliskiren
de réir: Atsuhiro Ichihara, et al.
Foilsithe / Cruthaithe: (2010-01-01)

Renin-Angiotensin-Aldosterone System Inhibitors, Statins, and Beta-Blockers in Diabetic Patients With Critical Limb Ischemia and Foot Lesions
de réir: Paolo Cimaglia MD, et al.
Foilsithe / Cruthaithe: (2022-05-01)

A systematic review of the role of renin angiotensin aldosterone system genes in diabetes mellitus, diabetic retinopathy and diabetic neuropathy
de réir: Zohreh Rahimi, et al.
Foilsithe / Cruthaithe: (2014-01-01)

Renin-angiotensin-aldosterone system inhibitors – a realm of confusion in COVID-19
de réir: Angela Madalina Lazar
Foilsithe / Cruthaithe: (2021-07-01)

Impact of the withdrawal of renin-angiotensin-aldosterone inhibitors on mortality in COVID-19 patients
de réir: Juan Caro-Codón, et al.
Foilsithe / Cruthaithe: (2022-10-01)

Effect of renin-angiotensin-aldosterone system inhibitors on Covid-19 patients in Korea.
de réir: Jungchan Park, et al.
Foilsithe / Cruthaithe: (2021-01-01)

Efficacy of astragalus combined with renin-angiotensin-aldosterone system blockers in the treatment of stage III diabetic nephropathy: a systematic review and meta-analysis
de réir: Yu-qiong Lin, et al.
Foilsithe / Cruthaithe: (2024-12-01)

Angiotensin II type 1 receptor antagonists and ACE inhibitors in the regulation of hemodynamics and renin-angiotensin-aldosterone system activity: focus on the organ protection
de réir: M. L. Maksimov, et al.
Foilsithe / Cruthaithe: (2010-04-01)

The Renin–Angiotensin–Aldosterone System and Coronavirus Disease 2019
de réir: Eliecer Coto, et al.
Foilsithe / Cruthaithe: (2021-03-01)

The Renin-Angiotensin-Aldosterone System in Vascular Inflammation and Remodeling
de réir: Maricica Pacurari, et al.
Foilsithe / Cruthaithe: (2014-01-01)